![]() |
|
|
University of Toronto Department of Nutritional Sciences Toronto, Ontario M5S 3E2 Canada
Dear Sir,
Ralph Holman's recent historical perspective on salient steps in
progress towards understanding the metabolism, biochemistry and
clinical significance of polyunsaturates (Holman 1998
) stimulated me to
comment on one of the enduring paradoxes in this field. On the one
hand, it is clear that there are two classes of polyunsaturates and
that provision of both in an appropriate ratio is necessary for normal
development. As Holman remarked, it took some effort to prove that
these fatty acids are necessary for humans as well as other mammals.
Throughout the period from their discovery to the present, linoleate
and the long chain (n-6) polyunsaturates have received the most
attention and have not faced the same skepticism about their
nutritional importance as the (n-3) polyunsaturates. On the other hand,
despite the lengthy and rich history of research in this field, the
paradox is that deficiency of linoleate alone has only recently been
reported (Cunnane and Anderson 1997
). The feeding of fat-free or
essential fatty acid (EFA) deficient diets containing various types of
saturated fatty acids has been reported on many occasions, but this has
always involved deficiency of all unsaturated fatty acids including not
only (n-6) and (n-3) polyunsaturates but also monounsaturates. Despite
an extensive review of the literature and discussions with many
researchers in the field including Ralph Holman about this subject, it
appears that the effects of feeding a complete diet excluding only
(n-6) polyunsaturates but including a source of (n-3) polyunsaturates
and oleate was not reported until 1997 (Cunnane and Anderson 1997
). Two
reports have addressed the impact of
-linolenate (18:3n-3) on growth
and development in rats otherwise fed a fat-free diet (Bourre et al. 1990
, Hansen and Jensen 1983
). The diets they used were still missing
oleate, which cannot be synthesized in adequate amounts to sustain
normal body oleate levels without an additional dietary oleate source
(Bourre et al. 1997
).
As a result of not having adequately studied linoleate deficiency
per se, it appears to have been assumed that 1)
EFA deficiency and linoleate deficiency are synonymous and 2)that linoleate requirements can be determined using EFA deficient
diets that lack nutrients other than linoleate, i.e. that are also
deficient in
-linolenate. I think that both these assumptions are
wrong, and as a result, for many years, we may have overestimated the
requirement for linoleate.
Despite losing body content of (n-6) polyunsaturates relative to
baseline levels, over 80 d linoleate deficient rats grew the same
as those consuming 2% of energy as linoleate and had few dermal
lesions (Cunnane and Anderson 1997
). This contrasts with the more
severe grow impairment and scaliness of the skin of EFA deficient rats
and supports previous work suggesting that as little as 0.4% of energy
as linoleate is probably sufficient if
-linolenate is present
in the diet (Bourre et al 1990
), which is not the case in EFA
deficiency. Despite the competitive interaction between linoleate and
-linolenate as reviewed by Holman (1998)
, they have similar and
relatively high rates of ß-oxidation. Thus a dual deficiency of
linoleate and
-linolenate would probably cause a more rapid
depletion of both fatty acids from body stores than either linoleate or
-linolenate deficiency alone. It would require more linoleate to
correct the deficiency symptoms than if
-linolenate was present in
the diet, thereby overestimating the dietary requirement for linoleate
alone. The slower depletion of (n-3) polyunsaturates from body stores
when linoleate is present in the diet may explain why it has been hard
to induce clear and consistent deficiency symptoms of (n-3)
polyunsaturates. Coincidentally, when
-linolenate is added to EFA
deficient diets, linoleate deficiency is also harder to induce (Bourre et al. 1990
, Cunnane and Anderson 1997
, Hansen and Jensen 1983
).
Linoleate is always present in diets deficient in (n-3) polyunsaturates
because suitable natural oils exist that contain linoleate with only
traces of
-linolenate, thereby avoiding the expense and effort
needed to prepare and feed diets containing specific free fatty acids.
However, for linoleate deficiency studies, no such natural oils exist
so that purified
-linolenate and oleate must be combined with a
dietary source of long chain saturates to provide all fatty acid types
excluding (n-6) polyunsaturates. This additional effort is necessary in
order to belatedly establish the true symptoms of linoleate deficiency
per se and it dietary requirements. Hence, paradoxically,
although a dietary requirement for linoleate became widely accepted
long before that of
-linolenate, knowledge of the effects of
linoleate deficiency per se and, more importantly, its true
requirement, appears to lag well behind that of the (n-3)
polyunsaturates.
Manuscript received September 5, 1998. Initial review completed November 5, 1998. Revision accepted November 5, 1998.
REFERENCES
1.
Bourre J. M., Dumont O. L., Clement M. E., Durand G.A.. Endogenous synthesis cannot compensate for absence of dietary oleic acid in rats. J. Nutr. 1997;127:488-493.
2. Bourre J. M., Piciotti M.., Dumont O., Pascal G., Durand G.. Dietary linoleic acid and polyunsaturated fatty acids in rat brain and other organsMinimal requirements of linoleic acid. Lipids 1990;25:465-472.[Medline]
3. Cunnane S. C., Anderson M. J.. Pure linoleate deficiency in the ratInfluence on growth, accumulation of n-6 polyunsaturates, and [1-14C]-linoleate oxidation. J. Lipid Res. 1997;38:805-812.[Abstract]
4. Hansen H. S., Jensen B.. Urinary prostaglandin E2 and vasopressin excretion in essential fatty acid deficient ratsEffect of linolenic acid supplementation. Lipids 1983;18:682-690.[Medline]
5. Holman R. T.. The slow discovery of the importance of omega 3 essential fatty acids in human health. J. Nutr. 1998;128:427S-433S.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||